Transplant Oncology in Evolution: Emerging Roles for Liver Transplant Beyond Hepatocellular Carcinoma.

Cancers (Basel) · 2026 · PMC13025092 · PMID 41899493

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Patients with detectable post-transplant ctDNA experienced recurrence at higher rates (50%) compared to those who were ctDNA-negative (25%), though this difference did not reach statistical significance in small cohorts.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.